NCT04289909 - Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

June 26, 2024

Study Completion Date

July 17, 2024

Conditions

Relapsing Remitting Multiple SclerosisProgressive Multiple SclerosisOptic NeuritisEye DiseasesOptic Nerve DiseasesNervous System DiseasesMultiple Sclerosis

Interventions

OTHER

Adaptive Optics Ophthalmoscopy (AOO)

AOO will permit to detect and quantify retinal perivascular inflammation in patients with MS in comparison to Healthy volunteers (control group)

Trial Locations (1)

Unknown

Institut du Cerveau et de la Moelle epiniere - Hopital Pitie Salpetriere, Paris